Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,959 | 19,766 | 27,455 | 33,101 | 8,662 |
| Receivables | 140 | 135 | 239 | 229 | 106 |
| TOTAL | $91,400 | $22,830 | $28,606 | $34,437 | $9,890 |
| Non-Current Assets | |||||
| PPE Net | 852 | 688 | 547 | 425 | 456 |
| Other Non-Current Assets | 98 | 78 | 80 | 81 | 18 |
| TOTAL | $949 | $766 | $627 | $506 | $475 |
| Total Assets | $92,349 | $23,596 | $29,233 | $34,942 | $10,365 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 3,735 | 2,583 | 2,147 | 1,538 | 2,294 |
| TOTAL | $3,811 | $2,618 | $2,200 | $3,103 | $2,373 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,585 | 1,577 | 1,571 | 1,566 | 1,542 |
| TOTAL | $94 | $0 | $0 | $0 | $14 |
| Total Liabilities | $3,905 | $2,618 | $2,200 | $3,103 | $2,387 |
| Shareholders' Equity | |||||
| Common Shares | 191,017 | 117,117 | 116,840 | 116,360 | 116,318 |
| Retained earnings | -152,869 | -146,507 | -137,766 | -131,004 | -123,495 |
| Other shareholders' equity | -3,296 | -2,787 | -4,122 | -4,161 | -2,795 |
| TOTAL | $90,029 | $22,555 | $28,604 | $33,405 | $9,520 |
| Total Liabilities And Equity | $93,934 | $25,173 | $30,804 | $36,508 | $11,907 |